|
CCT3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.616000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.361770E-02 |
| Normal-vs-Stage2 |
1.782420E-02 |
| Normal-vs-Stage3 |
1.097150E-01 |
| Normal-vs-Stage4 |
5.631600E-02 |
| Stage1-vs-Stage2 |
3.971000E-01 |
| Stage1-vs-Stage3 |
7.716200E-01 |
| Stage1-vs-Stage4 |
8.289000E-01 |
| Stage2-vs-Stage3 |
3.797400E-01 |
| Stage2-vs-Stage4 |
5.963000E-01 |
| Stage3-vs-Stage4 |
7.117600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.554000E-02 |
| Normal-vs-AfricanAmerican |
1.764420E-03 |
| Normal-vs-Asian |
2.216000E-02 |
| Caucasian-vs-AfricanAmerican |
2.565800E-02 |
| Caucasian-vs-Asian |
3.744800E-01 |
| AfricanAmerican-vs-Asian |
8.875500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.464200E-02 |
| Normal-vs-Female |
6.415400E-03 |
| Male-vs-Female |
9.035000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.253660E-02 |
| Normal-vs-Age(41-60Yrs) |
1.117180E-01 |
| Normal-vs-Age(61-80Yrs) |
8.983500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.224200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.263600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.475200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.729800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.184020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.048400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.587200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.052580E-01 |
| Classical-VS-Follicular |
1.377180E-01 |
| Classical-VS-Other |
6.907400E-01 |
| Classical-VS-Normal |
5.781300E-04 |
| Tall-VS-Follicular |
7.049200E-01 |
| Tall-VS-Other |
7.243800E-01 |
| Tall-VS-Normal |
7.471400E-01 |
| Follicular-VS-Other |
8.830400E-01 |
| Follicular-VS-Normal |
2.973800E-01 |
| Other-VS-Normal |
6.227200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.285900E-02 |
| Normal-vs-N1 |
8.995800E-01 |
| N0-vs-N1 |
7.802200E-02 |
|
|
